Click here to close now.




















Welcome!

News Feed Item

Frost & Sullivan Presents Goodwin Biotechnology with the Global Customer Value Leadership Award for Mammalian Biologics Contract Manufacturing

-- Goodwin Biotechnology pioneered best-in-class practices for the development of complex Biopharmaceuticals and Antibody Drug Conjugates (ADCs)

LONDON, Sept. 2, 2014 /PRNewswire/ -- Based on its recent analysis of the mammalian contract manufacturing services market, Frost & Sullivan recognises Goodwin Biotechnology with the 2014 Global Frost & Sullivan Award for Customer Value Leadership. Goodwin Biotechnology's reputation as one of the most trusted providers of mammalian contract manufacturing and development services has been built on more than 20 years of experience in the bioprocess development and cGMP manufacturing of mammalian cell culture-derived monoclonal antibodies (mAbs), vaccines, and recombinant proteins, and more than 10 years pioneering the field of bioconjugation.

Goodwin Biotechnology championed the concept of 'full integration' in the biopharmaceutical contract manufacturing space. It is a one-stop shop, offering its partners a comprehensive range of services from cell line development and proof-of-concept projects to bioprocess development and the manufacture of material for preclinical / Tox studies as well as early to late phase clinical trials.

Goodwin Biotechnology strives to be a highly flexible partner with its clients by finding customized solutions for the distinctive needs of every project and ensuring smooth implementation all throughout the lifecycle of an engagement. Furthermore, it has enhanced its brand value on a global basis by maintaining high levels of transparency and responsiveness while focusing on quality, and working within budgets and timelines.

The core services offered by Goodwin Biotechnology include cell line development through collaborations, cell culture and purification process development, cell banking, process scale-up, engineering runs for toxicology study materials, and strict adherence to current good manufacturing practices (cGMP) for manufacturing and providing Fill / Finish services for biopharmaceutical candidates used in human clinical trials. The company has also established best-in-class processes for the production of antibody drug conjugates (ADCs), cytotoxic ADCs (CADCs), antibody-chelator conjugates (for radioimmunoconjugates) and other bioconjugates.

"These core services are fully complemented and enhanced by the company's analytical and formulation development capabilities as well as its quality assurance, quality control, regulatory and project management capabilities," said Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram. "The complete and fully-integrated services offered by Goodwin Biotechnology reduce the supply chain complexities and timeline for clients to efficiently meet their preclinical and clinical needs."

"We at Goodwin Biotechnology are honored to be recognized for such a prestigious award, which showcases our orientation towards providing our clients with the best overall value proposition," noted Karl Pinto, CEO of Goodwin Biotechnology. "It is a testament to the company's rich and distinguished history, coupled with its innovative, state-of-the-art technologies, and highly skilled scientists that enables us to meet the expectations of customers across the globe and at various stages of their respective product development cycles. Having addressed challenges pertaining to the manufacturing of complex biological molecules, such as monoclonal antibodies, recombinant therapeutic proteins, vaccines and cytotoxic ADCs (CADCs), Goodwin Biotechnology helps our clients formulate a strategic approach with particular emphasis on critical protein product characterization, process development, and cGMP manufacturing for regulatory compliance."

"Goodwin Biotechnology's time-tested expertise with various host cell types and process optimisation techniques enables seamless technology transfers between R&D and GMP manufacturing for clinical studies," added Chidambaram. "It is one of the few contract manufacturing organisations to have installed capabilities for a number of robust and reproducible cell cultivation technologies, including disposable bioreactors such as, WAVE, perfusion, and stainless steel tank bioreactors."

At the start of every project, Goodwin Biotechnology focuses on optimising and refining the processes to maximize productivity and ensure seamless scale up. Towards that end, the company has hands-on experience in several chromatographic techniques including affinity, ion exchange, hydrophobic interaction, mixed mode, and size-exclusion chromatography. In addition, its ultrafiltration/diafiltration (UF/DF) processes use tangential flow filtration (TFF) technologies in both flat-plate and hollow-fiber formats.

Goodwin Biotechnology also addresses complex issues associated with antibody drug conjugates, including linker design, drug payload selection, and antibody stability in the production of multi-gram lots of conjugated antibodies used globally in clinical trials. Apart from its rich and varied expertise in protein modification through chemical conjugation and enzymatic digestion methods, Goodwin Biotechnology also offers unique specialties such as the production of Fab and F(ab')2 fragments and their subsequent purification as per client specifications.

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognises the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and, ultimately, customer base expansion.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About Goodwin Biotechnology

Goodwin Biotechnology is a world-class CMO that offers a Single Source Solution™ through partnerships with clients for cell line development or exploratory proof of concept projects through process development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and Antibody Drug Conjugates (ADCs) and other Biologic Drug Conjugates for early and late stage clinical trials. By working with Goodwin Biotechnology, our clients can enhance the value of their product candidates with clear development and manufacturing strategies as well as a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely, and cGMP compliant manner to enhance patients' lives. With over 20 years of experience as an independent contract manufacturer, Goodwin Biotechnology has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established and multi-national biopharmaceutical companies. Additional information may be found at http://www.GoodwinBio.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:   Start the discussion 
Join Us:      Join our community 
Subscribe:    Newsletter on "the next big thing" 
Register:     Gain access to visionary innovation

Contact:

Frost & Sullivan

Goodwin Biotechnology, Inc.

Melanie Parkinson

Robin McCallum, MSc

Best Practices, Frost & Sullivan

Manager of Business Development

E: [email protected]

[email protected]

P: +44 (0) 207 915 7867

+1 954-327-9656

T: @MelanieFrostBPA

www.GoodwinBio.com

www.awards.frost.com

[email protected]

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Through WebRTC, audio and video communications are being embedded more easily than ever into applications, helping carriers, enterprises and independent software vendors deliver greater functionality to their end users. With today’s business world increasingly focused on outcomes, users’ growing calls for ease of use, and businesses craving smarter, tighter integration, what’s the next step in delivering a richer, more immersive experience? That richer, more fully integrated experience comes ab...
SYS-CON Events announced today that Pythian, a global IT services company specializing in helping companies leverage disruptive technologies to optimize revenue-generating systems, has been named “Bronze Sponsor” of SYS-CON's 17th Cloud Expo, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Founded in 1997, Pythian is a global IT services company that helps companies compete by adopting disruptive technologies such as cloud, Big Data, advance...
Organizations from small to large are increasingly adopting cloud solutions to deliver essential business services at a much lower cost. According to cyber security experts, the frequency and severity of cyber-attacks are on the rise, causing alarm to businesses and customers across a variety of industries. To defend against exploits like these, a company must adopt a comprehensive security defense strategy that is designed for their business. In 2015, organizations such as United Airlines, Sony...
Culture is the most important ingredient of DevOps. The challenge for most organizations is defining and communicating a vision of beneficial DevOps culture for their organizations, and then facilitating the changes needed to achieve that. Often this comes down to an ability to provide true leadership. As a CIO, are your direct reports IT managers or are they IT leaders? The hard truth is that many IT managers have risen through the ranks based on their technical skills, not their leadership ab...
eCube Systems has released NXTmonitor, a full featured application orchestration solution. NXTmonitor, which inherited the code base of NXTminder, has been extended to support multi-discipline processes and will act as a DevOps utility in a heterogeneous enterprise environment. Previously, NXTminder was packaged with NXTera middleware to configure and manage Entera and NXTera RPC servers. “Since we are widening the focus of this solution to DevOps, we felt the need to change the name to NXTmon...
As more and more data is generated from a variety of connected devices, the need to get insights from this data and predict future behavior and trends is increasingly essential for businesses. Real-time stream processing is needed in a variety of different industries such as Manufacturing, Oil and Gas, Automobile, Finance, Online Retail, Smart Grids, and Healthcare. Azure Stream Analytics is a fully managed distributed stream computation service that provides low latency, scalable processing of ...
In today's digital world, change is the one constant. Disruptive innovations like cloud, mobility, social media, and the Internet of Things have reshaped the market and set new standards in customer expectations. To remain competitive, businesses must tap the potential of emerging technologies and markets through the rapid release of new products and services. However, the rigid and siloed structures of traditional IT platforms and processes are slowing them down – resulting in lengthy delivery ...
Amazon and Google have built software-defined data centers (SDDCs) that deliver massively scalable services with great efficiency. Yet, building SDDCs has proven to be a near impossibility for ‘normal’ companies without hyper-scale resources. In his session at 17th Cloud Expo, David Cauthron, founder and chief executive officer of Nimboxx, will discuss the evolution of virtualization (hardware, application, memory, storage) and how commodity / open source hyper converged infrastructure (HCI) so...
Enterprises can achieve rigorous IT security as well as improved DevOps practices and Cloud economics by taking a new, cloud-native approach to application delivery. Because the attack surface for cloud applications is dramatically different than for highly controlled data centers, a disciplined and multi-layered approach that spans all of your processes, staff, vendors and technologies is required. This may sound expensive and time consuming to achieve as you plan how to move selected applicati...
SYS-CON Events announced today that Micron Technology, Inc., a global leader in advanced semiconductor systems, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Micron’s broad portfolio of high-performance memory technologies – including DRAM, NAND and NOR Flash – is the basis for solid state drives, modules, multichip packages and other system solutions. Backed by more than 35 years of tech...
Contrary to mainstream media attention, the multiple possibilities of how consumer IoT will transform our everyday lives aren’t the only angle of this headline-gaining trend. There’s a huge opportunity for “industrial IoT” and “Smart Cities” to impact the world in the same capacity – especially during critical situations. For example, a community water dam that needs to release water can leverage embedded critical communications logic to alert the appropriate individuals, on the right device, as...
U.S. companies are desperately trying to recruit and hire skilled software engineers and developers, but there is simply not enough quality talent to go around. Tiempo Development is a nearshore software development company. Our headquarters are in AZ, but we are a pioneer and leader in outsourcing to Mexico, based on our three software development centers there. We have a proven process and we are experts at providing our customers with powerful solutions. We transform ideas into reality.
The web app is agile. The REST API is agile. The testing and planning are agile. But alas, data infrastructures certainly are not. Once an application matures, changing the shape or indexing scheme of data often forces at best a top down planning exercise and at worst includes schema changes that force downtime. The time has come for a new approach that fundamentally advances the agility of distributed data infrastructures. Come learn about a new solution to the problems faced by software organ...
SYS-CON Events announced today the Containers & Microservices Bootcamp, being held November 3-4, 2015, in conjunction with 17th Cloud Expo, @ThingsExpo, and @DevOpsSummit at the Santa Clara Convention Center in Santa Clara, CA. This is your chance to get started with the latest technology in the industry. Combined with real-world scenarios and use cases, the Containers and Microservices Bootcamp, led by Janakiram MSV, a Microsoft Regional Director, will include presentations as well as hands-on...
With the Apple Watch making its way onto wrists all over the world, it’s only a matter of time before it becomes a staple in the workplace. In fact, Forrester reported that 68 percent of technology and business decision-makers characterize wearables as a top priority for 2015. Recognizing their business value early on, FinancialForce.com was the first to bring ERP to wearables, helping streamline communication across front and back office functions. In his session at @ThingsExpo, Kevin Roberts...